MEP1B and early-onset autosomal dominant Alzheimer disease: Meprin β specifically cleaves in the N-terminal region of the amyloid precursor protein (APP), again at negatively charged amino acid residues [16], releasing two peptides that have been identified in the brain cerebrospinal fluid of patients with Alzheimer’s disease [17].